Nitecapone (INN; OR-462) is a drug which acts as a selective inhibitor of the enzyme catechol O-methyl transferase (COMT).

[1][2] It was patented as an antiparkinson medication but was never marketed.

[1] This drug article relating to the nervous system is a stub.

You can help Wikipedia by expanding it.